98%
921
2 minutes
20
Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) represent distinct autoimmune liver diseases, each with characteristic clinical, serological, and histological features. Rarely, patients may exhibit an overlap syndrome, presenting diagnostic and therapeutic challenges. We describe a 27-year-old woman with a longstanding history of childhood-onset AIH who subsequently developed clinical and serologic features consistent with PBC, fulfilling the Paris criteria for AIH-PBC overlap syndrome. Despite aggressive treatment with high-dose corticosteroids, she experienced rapid clinical deterioration, developing acute hepatic encephalopathy and requiring intensive care unit admission. A liver biopsy confirmed the coexistence of interface hepatitis (typical of AIH) and florid bile duct lesions (characteristic of PBC). Notably, the patient had a steroid-refractory course, systemic autoimmune comorbidities including ulcerative colitis and pyoderma gangrenosum, and exhibited atypical early-onset disease progression. Ultimately, due to severe and refractory liver failure, she required urgent liver transplantation evaluation. This case highlights the aggressive clinical course and critical management complexities of AIH-PBC overlap syndrome, emphasizing the importance of early recognition, comprehensive histologic evaluation, combined immunosuppressive and cholestatic therapies, and expedited referral for transplantation in refractory cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332042 | PMC |
http://dx.doi.org/10.7759/cureus.87519 | DOI Listing |
Funct Integr Genomics
September 2025
Department of Plastic Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Keloid scarring and Metabolic Syndrome (MS) are distinct conditions marked by chronic inflammation and tissue dysregulation, suggesting shared pathogenic mechanisms. Identifying common regulatory genes could unveil novel therapeutic targets. Methods.
View Article and Find Full Text PDFNeuropathol Appl Neurobiol
October 2025
Division of Rheumatology and Systemic Inflammatory Diseases, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Aims: Sarcoid myopathy (SaM) is characterised by granulomatous myositis (GM) and can overlap with inclusion body myositis (IBM), a late-onset chronic idiopathic inflammatory myopathy with a still enigmatic pathogenesis. As GM can occur in different clinical contexts, we aimed to examine the histomorphologic features and gene expression profiles in cases of definite SaM that may inform diagnostic and therapeutic considerations.
Methods: We performed a multidimensional characterisation of muscle biopsy specimens from patients with 'pure SaM' (n=17), SaM with concomitant IBM (SaM-IBM) (n=2), including histopathologic and ultrastructural analysis in addition to quantitative real-time polymerase chain reaction.
Eur J Case Rep Intern Med
August 2025
Charleston Area Medical Center, Charleston, USA.
Introduction: species, particularly , are rare opportunistic pathogens that typically affect immunocompromised individuals. These infections usually present with respiratory or systemic symptoms and are often linked to environmental exposure. Asymptomatic infections are exceedingly rare and pose unique diagnostic and therapeutic challenges.
View Article and Find Full Text PDFMini Rev Med Chem
September 2025
Department of PET/CT Diagnostic Imaging, Tianjin Medical University General Hospital, Tianjin 300052, China.
The diagnosis of adrenocortical tumors remains clinically challenging due to overlapping morphological and functional features between benign, malignant, and hormonally active lesions. Malignant and functional tumors are frequently associated with poor prognosis. Traditional morphological imaging methods, such as CT and MRI, cannot reliably distinguish lesion types.
View Article and Find Full Text PDFIn recent years, several biologics have been introduced into hospitals and clinics as alternatives to surgery and/or topical/oral cortisone therapy in patients with severe refractory chronic rhinosinusitis with polyps (CRSwNP). Advances in understanding the pathophysiology of CRSwNP in relation to the predominant type 2 endotype have also paved the way for understanding possible overlaps with hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA). In this article, we present the biologic treatment options currently approved in Germany for the treatment of severe CRSwNP - dupilumab, omalizumab and mepolizumab - together with guidance on practical management including side effects for the indication of CRSwNP.
View Article and Find Full Text PDF